Genomic imbalances and MYB fusion in synchronous bilateral adenoid cystic carcinoma and invasive lobular carcinoma of the breast

Kovács,Anikó; Persson,Fredrik; Persson,Marta; Andersson,Mattias   K.; Stenman,Göran

doi:10.3892/mco.2017.1330

Genomic imbalances and MYB fusion in synchronous bilateral adenoid cystic carcinoma and invasive lobular carcinoma of the breast

Authors:
- Anikó Kovács
- Fredrik Persson
- Marta Persson
- Mattias K. Andersson
- Göran Stenman
View Affiliations

Affiliations: Department of Clinical Pathology and Genetics, Sahlgrenska University Hospital, Gothenburg, Sweden, Department of Pathology and Genetics, Sahlgrenska Cancer Center, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Published online on: July 18, 2017 https://doi.org/10.3892/mco.2017.1330
Pages: 322-326
Copyright: © Kovács et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The incidence of synchronous bilateral breast carcinomas (BBCs) has increased with a more frequent use of magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer. A total of 30% of all BBCs occur synchronously. In the present study, we describe a unique case of synchronous BBC in a 59‑year‑old previously healthy woman with no known family history of breast or ovarian cancer. At the time of diagnosis the patient had an invasive lobular carcinoma (ILC) in the right breast and an adenoid cystic carcinoma (ACC) in the left breast. To the best of our knowledge, this is the first published case of bilateral, simultaneously occurring ACC and ILC of the breast. Genome‑wide genomic profiling of the tumors revealed that they had distinctly different genomic imbalances. The ACC had a 5.7 Mb interstitial 6q deletion with a breakpoint located in the 3'‑part of MYB, resulting in loss of the last coding exon of MYB and its 3'‑UTR. RT‑PCR analysis confirmed that the tumor expressed an ACC‑specific MYB‑NFIB fusion transcript. In contrast, the ILC had no rearrangements of 6q or MYB‑NFIB gene fusion but showed instead gain of 1q21.1‑qter, loss of 16q11.2‑qter, and 22q12.2‑q12.3 as the sole genomic imbalances. Notably, concurrent gains of 1q and losses of 16q are characteristic features of ILC. Collectively, our findings indicate that the ACC and ILC had originated independently of each other and that the MYB‑NFIB fusion is a specific biomarker for breast ACC.

View Figures

View References

1	Hungness ES, Safa M, Shaughnessy EA, Aron BS, Gazder PA, Hawkins HH, Lower EE, Seeskin C, Yassin RS and Hasselgren PO: Bilateral synchronous breast cancer: Mode of detection and comparison of histologic features between the 2 breasts. Surgery. 128:702–707. 2000. View Article : Google Scholar : PubMed/NCBI
2	Hartman M, Czene K, Reilly M, Adolfsson J, Bergh J, Adami H-O, Dickman PW and Hall P: Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol. 25:4210–4216. 2007. View Article : Google Scholar : PubMed/NCBI
3	MacGrogan G, Tot T, Rakha E and Morrow M: Bilateral breast carcinoma and nonsynchronous breast carcinomaWHO Classification of Tumours of the Breast. Lakhani SR, Ellis OI, Schnitt SJ, Tan PH and van de Vijver MJ: 4. 4th edition. IARC; Lyon: pp. 69–70. 2012
4	Huo D, Melkonian S, Rathouz PJ, Khramtsov A and Olopade OI: Concordance in histological and biological parameters between first and second primary breast cancers. Cancer. 117:907–915. 2011. View Article : Google Scholar : PubMed/NCBI
5	Holm M, Tjønneland A, Balslev E and Kroman N: Prognosis of synchronous bilateral breast cancer: A review and meta-analysis of observational studies. Breast Cancer Res Treat. 146:461–475. 2014. View Article : Google Scholar : PubMed/NCBI
6	Brennan ME, Houssami N, Lord S, Macaskill P, Irwig L, Dixon JM, Warren RM and Ciatto S: Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: Systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol. 27:5640–5649. 2009. View Article : Google Scholar : PubMed/NCBI
7	Senkus E, Szade J, Pieczyńska B, Zaczek A, Pikiel J, Sosińska-Mielcarek K, Karpińska A and Jassem J: Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype. Int J Clin Exp Pathol. 7:353–363. 2013.PubMed/NCBI
8	Chen Y, Thompson W, Semenciw R and Mao Y: Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev. 8:855–861. 1999.PubMed/NCBI
9	Singletary SE: Rating the risk factors for breast cancer. Ann Surg. 237:474–482. 2003. View Article : Google Scholar : PubMed/NCBI
10	Adami H-O, Hansen J, Jung B and Rimsten A: Characteristics of familial breast cancer in Sweden: Absence of relation to age and unilateral versus bilateral disease. Cancer. 48:1688–1695. 1981. View Article : Google Scholar : PubMed/NCBI
11	Polednak AP: Bilateral synchronous breast cancer: A population-based study of characteristics, method of detection, and survival. Surgery. 133:383–389. 2003. View Article : Google Scholar : PubMed/NCBI
12	Jobsen JJ, van der Palen J, Ong F, Riemersma S and Struikmans H: Bilateral breast cancer, synchronous and metachronous; differences and outcome. Breast Cancer Res Treat. 153:277–283. 2015. View Article : Google Scholar : PubMed/NCBI
13	Song F, Li X, Song F, Zhao Y, Li H, Zheng H, Gao Z, Wang J, Zhang W and Chen K: Comparative genomic analysis reveals bilateral breast cancers are genetically independent. Oncotarget. 6:31820–31829. 2015. View Article : Google Scholar : PubMed/NCBI
14	Fountzilas E, Kotoula V, Zagouri F, Giannoulatou E, Kouvatseas G, Pentheroudakis G, Koletsa T, Bobos M, Papadopoulou K, Samantas E, et al: Disease evolution and heterogeneity in bilateral breast cancer. Am J Cancer Res. 6:2611–2630. 2016.PubMed/NCBI
15	Persson M, Andrén Y, Moskaluk CA, Frierson HF Jr, Cooke SL, Futreal PA, Kling T, Nelander S, Nordkvist A, Persson F and Stenman G: Clinically significant copy number alterations and complex rearrangements of MYBNFIB in head and neck adenoid cystic carcinoma. Genes Chromosomes Cancer. 51:805–817. 2012. View Article : Google Scholar : PubMed/NCBI
16	Jee KJ, Persson M, Heikinheimo K, Passador-Santos F, Aro K, Knuutila S, Odell EW, Mäkitie A, Sundelin K, Stenman G and Leivo I: Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma. Mod Pathol. 26:213–222. 2013. View Article : Google Scholar : PubMed/NCBI
17	Persson M, Andrén Y, Mark J, Horlings HM, Persson F and Stenman G: Recurrent fusion of MYBNFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 106:18740–18744. 2009. View Article : Google Scholar : PubMed/NCBI
18	Andersson MK and Stenman G: The landscape of gene fusions and somatic mutations in salivary gland neoplasms - Implications for diagnosis and therapy. Oral Oncol. 57:63–69. 2016. View Article : Google Scholar : PubMed/NCBI
19	Fehr A, Kovács A, Löning T, Frierson H Jr, van den Oord J and Stenman G: The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma. J Pathol. 224:322–327. 2011. View Article : Google Scholar : PubMed/NCBI
20	Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, et al: The mutational landscape of adenoid cystic carcinoma. Nat Genet. 45:791–798. 2013. View Article : Google Scholar : PubMed/NCBI
21	Martelotto LG, De Filippo MR, Ng CK, Natrajan R, Fuhrmann L, Cyrta J, Piscuoglio S, Wen HC, Lim RS, Shen R, et al: Genomic landscape of adenoid cystic carcinoma of the breast. J Pathol. 237:179–189. 2015. View Article : Google Scholar : PubMed/NCBI
22	Stenman G, Sandros J, Dahlenfors R, Juberg-Ode M and Mark J: 6q- and loss of the Y chromosome - two common deviations in malignant human salivary gland tumors. Cancer Genet Cytogenet. 22:283–293. 1986. View Article : Google Scholar : PubMed/NCBI
23	Nordkvist A, Mark J, Gustafsson H, Bang G and Stenman G: Non-random chromosome rearrangements in adenoid cystic carcinoma of the salivary glands. Genes Chromosomes Cancer. 10:115–121. 1994. View Article : Google Scholar : PubMed/NCBI
24	Brayer KJ, Frerich CA, Kang H and Ness SA: Recurrent fusions in MYBMYBL1 define a common, transcription factor-driven oncogenic pathway in salivary gland adenoid cystic carcinoma. Cancer Discov. 6:176–187. 2016. View Article : Google Scholar : PubMed/NCBI
25	Drier Y, Cotton MJ, Williamson KE, Gillespie SM, Ryan RJ, Kluk MJ, Carey CD, Rodig SJ, Sholl LM, Afrogheh AH, et al: An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet. 48:265–272. 2016. View Article : Google Scholar : PubMed/NCBI
26	Brill LB II, Kanner WA, Fehr A, Andrén Y, Moskaluk CA, Löning T, Stenman G and Frierson HF Jr: Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol. 24:1169–1176. 2011. View Article : Google Scholar : PubMed/NCBI
27	Wetterskog D, Lopez-Garcia MA, Lambros MB, A'Hern R, Geyer FC, Milanezi F, Cabral MC, Natrajan R, Gauthier A, Shiu K, et al: Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. J Pathol. 226:84–96. 2012. View Article : Google Scholar : PubMed/NCBI
28	Wetterskog D, Wilkerson PM, Rodrigues DN, Lambros MB, Fritchie K, Andersson MK, Natrajan R, Gauthier A, Di Palma S, Shousha S, et al: Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations. Histopathology. 62:543–550. 2013. View Article : Google Scholar : PubMed/NCBI
29	Sapino A, Sneige N and Eusebi V: Adenoid cystic carcinomaWHO Classification of Tumours of the Breast. Lakhani SR, Ellis OI, Schnitt SJ, Tan PH and van de Vijver MJ: 4. 4th edition. IARC; Lyon: pp. 56–57. 2012
30	Foschini MP, Morandi L, Asioli S, Giove G, Corradini AG and Eusebi V: The morphological spectrum of salivary gland type tumours of the breast. Pathology. 49:215–227. 2017. View Article : Google Scholar : PubMed/NCBI
31	Stenman G, Licitra L, Said-Al-Naief N, van Zante A and Yarbrough WG: Adenoid cystic carcinomaWHO Classification of Head and Neck Tumours. 9. 4th edition. El-Naggar AK, Chan JKC, Grandis JR, Takata T and Slootweg PJ: IARC; Lyon: pp. 164–165. 2017
32	Hungermann D, Schmidt H, Natrajan R, Tidow N, Poos K, Reis-Filho JS, Brandt B, Buerger H and Korsching E: Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer. J Pathol. 224:517–528. 2011. View Article : Google Scholar : PubMed/NCBI
33	Stacher E, Boldt V, Leibl S, Halbwedl I, Popper HH, Ullmann R, Tavassoli FA and Moinfar F: Chromosomal aberrations as detected by array comparative genomic hybridization in early low-grade intraepithelial neoplasias of the breast. Histopathology. 59:549–555. 2011. View Article : Google Scholar : PubMed/NCBI
34	Lakhani SR, Rakha E and Simpson PT: WHO Classification of Tumours of the Breast. Lakhani SR, Ellis OI, Schnitt SJ, Tan PH and van de Vijver MJ: 4. 4th edition. IARC; Lyon: pp. 40–42. 2012
35	Stenman G, Andersson MK and Andrén Y: New tricks from an old oncogene: Gene fusion and copy number alterations of MYB in human cancer. Cell Cycle. 9:2986–2995. 2010. View Article : Google Scholar : PubMed/NCBI
36	Tse GMK, Kung FYL, Chan ABW, Law BKB, Chang AR and Lo K-W: Clonal analysis of bilateral mammary carcinomas by clinical evaluation and partial allelotyping. Am J Clin Pathol. 120:168–174. 2003. View Article : Google Scholar : PubMed/NCBI
37	Saad RS, Denning KL, Finkelstein SD, Liu Y, Pereira TC, Lin X and Silverman JF: Diagnostic and prognostic utility of molecular markers in synchronous bilateral breast carcinoma. Mod Pathol. 21:1200–1207. 2008. View Article : Google Scholar : PubMed/NCBI
38	Di Bonito M, Cantile M, Cerrone M, Liguori G and Botti G: Synchronous pleomorphic adenoma and invasive ductal carcinoma in distinct breasts. Breast J. 21:428–430. 2015. View Article : Google Scholar : PubMed/NCBI
39	Da Silva L, Buck L, Simpson PT, Reid L, McCallum N, Madigan BJ and Lakhani SR: Molecular and morphological analysis of adenoid cystic carcinoma of the breast with synchronous tubular adenosis. Virchows Arch. 454:107–114. 2009. View Article : Google Scholar : PubMed/NCBI